Clinicopathological features of endoscopically treated early gastric cancer with lymphovascular infiltration
- PMID: 36581687
- PMCID: PMC11796520
- DOI: 10.1007/s00432-022-04536-7
Clinicopathological features of endoscopically treated early gastric cancer with lymphovascular infiltration
Abstract
Purpose: Lymphovascular infiltration (LVI) may play a critical role in radicality and prognostic assessment of early gastric cancer (EGC). However, risk factors for LVI in endoscopically resected EGC remain unknown. This study evaluated the clinicopathological characteristics and prognoses of patients who underwent endoscopic resection of EGC to identify potential risk factors of LVI.
Methods: A cross-sectional study of patients who received gastric endoscopic submucosal dissection between February 1, 2012, and December 31, 2019, at two institutions was conducted. Among 1,462 lesions, 943 met the criteria for radical treatment considering features other than LVI and were included. The lesions were classified based on the presence of LVI. The clinicopathological characteristics of the two groups were compared.
Results: LVI was detected in 17 lesions (1.8%). The positivity rates of LVI were 0.7% (7/903) for intramucosal cancer and 25% (10/40) for submucosally invasive cancer. The LVI positivity rate was significantly higher for mixed-type cancer (lesions containing differentiated and undifferentiated-type carcinoma) than for non-mixed-type cancer (35.3 vs. 2.8%; P < 0.001) and for submucosally invasive cancer than for intramucosal cancer (58.8 vs. 3.2%; P < 0.001). In the multivariate logistic regression analysis, independent risk factors for LVI were mixed-type cancer (odds ratio; 95% confidence interval: 23.9; 5.0-115; P < 0.001) and submucosal invasion (58.7; 16.0-215; P < 0.001).
Conclusions: Mixed-type cancer and submucosal invasion were risk factors for LVI in endoscopically resected EGC. These factors may play a critical role in the radicality and prognostic assessment of EGC.
Keywords: Early gastric cancer; Endoscopic submucosal dissection; Lymphovascular infiltration; Mixed-type cancer; Submucosal invasion.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Tumor Budding as an Additional Factor in Determining the Need for Surgery after Endoscopic Resection in Mucosal Invasive Gastric Cancer: A Retrospective Study from a Korean Tertiary Hospital.Gut Liver. 2025 Jul 15;19(4):559-568. doi: 10.5009/gnl240352. Epub 2025 Apr 1. Gut Liver. 2025. PMID: 40169390 Free PMC article.
-
Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.World J Gastroenterol. 2013 Mar 7;19(9):1424-37. doi: 10.3748/wjg.v19.i9.1424. World J Gastroenterol. 2013. PMID: 23539431 Free PMC article.
-
The incidence of lymph node metastasis in early gastric cancer according to the expanded criteria in comparison with the absolute criteria of the Japanese Gastric Cancer Association: a systematic review of the literature and meta-analysis.Gastrointest Endosc. 2018 Feb;87(2):338-347. doi: 10.1016/j.gie.2017.09.025. Epub 2017 Sep 28. Gastrointest Endosc. 2018. PMID: 28966062
-
Clinical Significance of Lymphatic Involvement in Intramucosal (pT1a) Gastric Cancer Resected by Endoscopic Submucosal Dissection.J Gastroenterol Hepatol. 2025 Mar;40(3):712-719. doi: 10.1111/jgh.16854. Epub 2024 Dec 18. J Gastroenterol Hepatol. 2025. PMID: 39690969
-
Clinical feasibility and oncologic safety of primary endoscopic submucosal dissection for clinical submucosal invasive early gastric cancer.J Cancer Res Clin Oncol. 2021 Oct;147(10):3051-3061. doi: 10.1007/s00432-021-03581-y. Epub 2021 Mar 5. J Cancer Res Clin Oncol. 2021. PMID: 33666751 Free PMC article.
Cited by
-
Clinical outcome of non-curative endoscopic submucosal dissection for early gastric cancer.J Gastrointest Oncol. 2024 Apr 30;15(2):566-576. doi: 10.21037/jgo-24-168. Epub 2024 Apr 28. J Gastrointest Oncol. 2024. PMID: 38756642 Free PMC article.
-
Development of a multimodal predictive model using PET/CT radiomics and clinical data for preoperative assessment of lymphovascular invasion in gastric cancer.Am J Transl Res. 2025 Jul 15;17(7):5441-5452. doi: 10.62347/PBNU9406. eCollection 2025. Am J Transl Res. 2025. PMID: 40821083 Free PMC article.
References
-
- Gotoda T, Sasako M, Ono H, Katai H, Sano T, Shimoda T (2001) Evaluation of the necessity for gastrectomy with lymph node dissection for patients with submucosal invasive gastric cancer. Br J Surg 88:444–449. 10.1046/j.1365-2168.2001.01725.x - PubMed
-
- Gotoda T, Yamamoto H, Soetikno RM (2006) Endoscopic submucosal dissection of early gastric cancer. J Gastroenterol 41:929–942. 10.1007/s00535-006-1954-3 - PubMed
-
- Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, Kato Y (2000) Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 3:219–225. 10.1007/pl00011720 - PubMed
-
- Hanaoka N, Tanabe S, Mikami T, Okayasu I, Saigenji K (2009) Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection. Endoscopy 41:427–432. 10.1055/s-0029-1214495 - PubMed
-
- Hatta W, Gotoda T, Oyama T, Kawata N, Takahashi A, Yoshifuku Y et al (2017) A scoring system to stratify curability after endoscopic submucosal dissection for early gastric cancer: “eCura system.” Am J Gastroenterol 112:874–881. 10.1038/ajg.2017.95 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous